TY - JOUR
T1 - Association de biothérapies au cours des maladies inflammatoires chroniques intestinales
T2 - Quel intérêt en pratique ?
AU - Filippi, Jerôme
AU - Ben-Horin, Shomron
AU - Hebuterne, Xavier
AU - Roblin, Xavier
N1 - Publisher Copyright:
Copyright © 2019 John Libbey Eurotext.
PY - 2018/12
Y1 - 2018/12
N2 - The current armamentarium for inflammatory bowel diseases has dramatically evolved those last years, as well as our therapeutic goals. However, many patients still have active diseases, highlighting unmet needs and interest for novel strategies, such as combining biologic therapies. The aim of this article is to report the current published data regarding the efficacy and safety of the combination of biologics in immune-mediated inflammatory diseases, and particularly in inflammatory bowel diseases.
AB - The current armamentarium for inflammatory bowel diseases has dramatically evolved those last years, as well as our therapeutic goals. However, many patients still have active diseases, highlighting unmet needs and interest for novel strategies, such as combining biologic therapies. The aim of this article is to report the current published data regarding the efficacy and safety of the combination of biologics in immune-mediated inflammatory diseases, and particularly in inflammatory bowel diseases.
KW - Biotherapies
KW - Inflammatory bowel diseases
KW - Therapeutic strategies
UR - http://www.scopus.com/inward/record.url?scp=85059386208&partnerID=8YFLogxK
U2 - 10.1684/hpg.2018.1664
DO - 10.1684/hpg.2018.1664
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:85059386208
SN - 2115-3310
VL - 25
SP - 1021
EP - 1027
JO - Hepato-Gastro et Oncologie Digestive
JF - Hepato-Gastro et Oncologie Digestive
IS - 10
ER -